跳至主要内容
临床试验/EUCTR2005-005664-88-GB
EUCTR2005-005664-88-GB进行中(未招募)1 期

Prospective Study of Mycobacterium Tuberculosis Specific Cellular immune Responses in Iatrogenically Immunosuppressed Patients: those undergoing TNF-alpha blockade or Awaiting Renal Trasnplants: A Potential New Method For Accurate Diagnosis of Latent Tuberculosis Infection in Clinical Practice - Diagnosis of Latent TB Infection in Anti-TNF alpha or Dialysis

niversity of Oxford0 个研究点目标入组 520 人开始时间: 2005年12月15日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
520

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients in chronic renal failure who are potential transplant recipients
  • Patients with a rheumatological condition who are potential recipients of Tumour Necrosis Factor alpha blockade
  • adult (over 18)
  • able to give written informed consent
  • with risk factors for tuberculosis:
  • -[renal arm] from collaborating units in high prevalence areas of the UK
  • -[anti TNF alpha arm] patients who would be considered for tuberculin skin testing under current anti-TNFalpha treatment guidelines, including past history of exposure or disease, immigrant from high prevalence area, CXR changes suggestive of prior TB, grade 2 heaf test or above
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Current active tuberculosis
  • Unable to give written informed consent
  • Hypersensitivity to tuberculin

研究者

相似试验